{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:04Z","timestamp":1791860464928,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/MB\/CEPI\/2016"],"award-info":[{"award-number":["BT\/MB\/CEPI\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijbiomac.2024.132332","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T11:21:55Z","timestamp":1716031315000},"page":"132332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"P2","title":["Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9832-2830","authenticated-orcid":false,"given":"Shaban","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-4804","authenticated-orcid":false,"given":"Akash Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-8928","authenticated-orcid":false,"given":"Nagmi","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-6828","authenticated-orcid":false,"given":"Khalid","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-7873","authenticated-orcid":false,"given":"Janmejay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-9743","authenticated-orcid":false,"given":"Guruprasad R.","family":"Medigeshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-8327","authenticated-orcid":false,"given":"Rajesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-3514","authenticated-orcid":false,"given":"Hemant K.","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2024.132332_bb0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global tuberculosis report 2020 - reflections on the Global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1213\/ANE.0000000000004845","article-title":"Coronaviruses and SARS-CoV-2: a brief overview","volume":"131","author":"Ludwig","year":"2020","journal-title":"Anesth. Analg."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132332_bb0015","article-title":"Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: an in silico study","volume":"17","author":"Ahmad","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0020","series-title":"Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis","first-page":"79","article-title":"Mobile technology solution for COVID-19: surveillance and prevention","author":"Ahmad","year":"2021"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0025","first-page":"1","article-title":"Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study","author":"Alghamdi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.132332_bb0030","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/molecules27144391","article-title":"In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2","volume":"27","author":"Alturki","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132332_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/medicina58040515","article-title":"Hemi-babim and fenoterol as potential inhibitors of MPro and papain-like protease against SARS-CoV-2: an in-silico study","volume":"58","author":"Alzamami","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10753-022-01734-w","article-title":"SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine stimulation, an increasing antigenic and anti-inflammatory cytokine induction, and rising structural protein instability: a minimal number genome-based approach","volume":"46","author":"Barh","year":"2022","journal-title":"Inflammation"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.132332_bb0045","article-title":"In silico analysis of ACE2 receptor to find potential herbal drugs in COVID-19 associated neurological dysfunctions","volume":"17","author":"Hou","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0050","series-title":"Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis","first-page":"123","article-title":"A review on predictive systems and data models for covid-19","author":"Khan","year":"2021"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132332_bb0055","article-title":"Antiviral potential of Indian medicinal plants against influenza and SARS-CoV: a systematic review","volume":"17","author":"Khuntia","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0060","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s11010-020-04027-8","article-title":"Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis","volume":"476","author":"Tarique","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132332_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijtb.2020.06.001","article-title":"COVID 19 and tuberculosis","volume":"67","author":"Chopra","year":"2020","journal-title":"Indian J. Tuberc."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.132332_bb0070","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3201\/eid2611.203163","article-title":"Worldwide effects of coronavirus disease pandemic on tuberculosis services, January\u2013April 2020","volume":"26","author":"Migliori","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132332_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pulmoe.2020.12.008","article-title":"Functional impairment during post-acute COVID-19 phase: preliminary finding in 56 patients","volume":"27","author":"Zampogna","year":"2021","journal-title":"Pulmonology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132332_bb0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.132332_bb0085","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s40265-020-01421-w","article-title":"Immune therapy, or antiviral therapy, or both for COVID-19: a systematic review","volume":"80","author":"Cantini","year":"2020","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0090","article-title":"Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis","volume":"25","author":"Sheerin","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino","year":"2019","journal-title":"Front. Pediatr."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0006-2016","article-title":"Regulation of immunity to tuberculosis","volume":"4","author":"Brighenti","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0105","doi-asserted-by":"crossref","first-page":"646333","DOI":"10.3389\/fimmu.2021.646333","article-title":"Cellular immune response to COVID-19 and potential immune modulators","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132332_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","article-title":"New agents for the treatment of drug-resistant Mycobacterium tuberculosis","volume":"102","author":"Hoagland","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0120","first-page":"411","article-title":"The granuloma in tuberculosis: dynamics of a host-pathogen collusion","volume":"3","author":"Ehlers","year":"2012","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.132332_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157914","article-title":"Inflammatory response in COVID-19 patients resulting from the interaction of the inflammasome and SARS-CoV-2","volume":"22","author":"Cheon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cels.2021.05.015","article-title":"Advances in systems biology modeling: 10 years of crowdsourcing DREAM challenges","volume":"12","author":"Pablo","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0140","doi-asserted-by":"crossref","first-page":"120761","DOI":"10.1016\/j.lfs.2022.120761","article-title":"MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies","volume":"305","author":"Panda","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0145","doi-asserted-by":"crossref","first-page":"e13043","DOI":"10.1111\/sji.13043","article-title":"Coronavirus infection: an immunologists\u2019 perspective","volume":"93","author":"De Sanctis","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0150","doi-asserted-by":"crossref","first-page":"631226","DOI":"10.3389\/fimmu.2021.631226","article-title":"Inflammation and antiviral immune response associated with severe progression of COVID-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.132332_bb0155","doi-asserted-by":"crossref","first-page":"e0162220","DOI":"10.1371\/journal.pone.0162220","article-title":"The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis","volume":"11","author":"Blankley","year":"2016","journal-title":"PLoS One"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2024.132332_bb0160","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"suppl_1","key":"10.1016\/j.ijbiomac.2024.132332_bb0165","doi-asserted-by":"crossref","first-page":"D258","DOI":"10.1093\/nar\/gkh036","article-title":"The Gene Ontology (GO) database and informatics resource","volume":"32","author":"Consortium, GO","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0170","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"Mering","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132332_bb0180","first-page":"1","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0190","series-title":"4: Protein Preparation Wizard","author":"Release","year":"2016"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0195","series-title":"Maestro, Schr\u00f6dinger, LLC, New York, NY, 2017","author":"Release","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132332_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0210","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"Jorgensen","year":"1988","journal-title":"J. Am. Chem. Soc."},{"issue":"80","key":"10.1016\/j.ijbiomac.2024.132332_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0220","series-title":"LLC. New York, NY, 2017","author":"LigPrep","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0225","first-page":"1","article-title":"Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study","author":"Ahmad","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0230","first-page":"1","article-title":"Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study","author":"Ahmad","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0235","first-page":"1","article-title":"Comprehensive computational studies of naturally occurring kuguacins as antidiabetic agents by targeting visfatin","author":"Famuyiwa","year":"2023","journal-title":"Chem. Afr."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0240","doi-asserted-by":"crossref","first-page":"135701","DOI":"10.1016\/j.molstruc.2023.135701","article-title":"Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog","volume":"1287","author":"Rana","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132332_bb0245","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/0929867330666230309143711","article-title":"Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis","volume":"31","author":"Shah","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0250","series-title":"Computer Aided Drug Design (CADD): From Ligand-based Methods to Structure-based Approaches","first-page":"125","article-title":"Fundamentals of molecular modeling in drug design","author":"Tripathi","year":"2022"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.132332_bb0255","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0260","series-title":"LLC. New York, NY, 2017","author":"Glide","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0265","series-title":"LLC. New York, NY","author":"QikProp","year":"2019"},{"issue":"38","key":"10.1016\/j.ijbiomac.2024.132332_bb0270","doi-asserted-by":"crossref","first-page":"24891","DOI":"10.1021\/acsomega.1c03736","article-title":"Theoretical studies on the molecular properties, toxicity, and biological efficacy of 21 new chemical entities","volume":"6","author":"Srivastava","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0275","doi-asserted-by":"crossref","first-page":"130880","DOI":"10.1016\/j.molstruc.2021.130880","article-title":"Synthesis, spectra (FT-IR, NMR) investigations, DFT study, in silico ADMET and molecular docking analysis of 2-amino-4-(4-aminophenyl) thiophene-3-carbonitrile as a potential anti-tubercular agent","volume":"1244","author":"Obu","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/wcms.81","article-title":"The ORCA program system","volume":"2","author":"Neese","year":"2012","journal-title":"WIREs Comput. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0285","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1002\/wcms.1327","article-title":"Software update: the ORCA program system, version 4.0","volume":"8","author":"Neese","year":"2018","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0290","series-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00268977200100031","article-title":"NpT-ensemble Monte Carlo calculations for binary liquid mixtures","volume":"23","author":"McDonald","year":"1972","journal-title":"Mol. Phys."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132332_bb0300","doi-asserted-by":"crossref","first-page":"e1011196","DOI":"10.1371\/journal.ppat.1011196","article-title":"1, BA. 2 and BA. 2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies","volume":"19","author":"Singh","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fimmu.2013.00371","article-title":"Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells","volume":"4","author":"Chmielewski","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0310","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132332_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14304\/SURYA.JPR.V2N6.1","article-title":"Targeting interleukin-2-inducible T-cell kinase (ITK) in T-cell related diseases","volume":"2","author":"Zhong","year":"2014","journal-title":"Postdoc. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132332_bb0320","first-page":"3999","article-title":"DNA-binding specificity of GATA family transcription factors","volume":"13","author":"Merika","year":"1993","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132332_bb0325","doi-asserted-by":"crossref","first-page":"a002279","DOI":"10.1101\/cshperspect.a002279","article-title":"ZAP-70: an essential kinase in T-cell signaling","volume":"2","author":"Wang","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132332_bb0330","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.4049\/jimmunol.162.7.3859","article-title":"The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells","volume":"162","author":"Kellermann","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132332_bb0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065X.2003.00073.x","article-title":"The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity","volume":"195","author":"M\u00fcller","year":"2003","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132332_bb0340","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.147.9.3165","article-title":"The T cell activation antigen CD27 is a member of the nerve growth factor\/tumor necrosis factor receptor gene family","volume":"147","author":"Camerini","year":"1991","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132332_bb0345","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20030916","article-title":"CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool","volume":"198","author":"Hendriks","year":"2003","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132332_bb0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/stem.5530120502","article-title":"The activation antigen CD69","volume":"12","author":"Ziegler","year":"1994","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132332_bb0355","first-page":"519","article-title":"Structure and function of lymphocyte TCR\/CD3 complex","volume":"57","author":"Bo\u0107ko","year":"2003","journal-title":"Postepy Hig. Med. Dosw."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132332_bb0360","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0021-9258(17)49904-2","article-title":"The structural basis of T-cell receptor (TCR) activation: an enduring enigma","volume":"295","author":"Mariuzza","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0365","doi-asserted-by":"crossref","first-page":"762594","DOI":"10.3389\/fimmu.2021.762594","article-title":"CD247, a potential T cell-derived disease severity and prognostic biomarker in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132332_bb0370","first-page":"791","article-title":"A brief review on importance of DFT in drug design","volume":"7","author":"Tandon","year":"2019","journal-title":"Res. Med. Eng. Sci"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024031374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024031374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:27:11Z","timestamp":1790612831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024031374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":74,"alternative-id":["S0141813024031374"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132332","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132332"}}